Global Avian Influenza Vaccines Market Growth 2021-2026

Publisher Name :
Date: 06-Jul-2021
No. of pages: 126

According to this latest study, the 2021 growth of Avian Influenza Vaccines will have significant change from previous year. By the most conservative estimates of global Avian Influenza Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 894.1 million in 2020. Over the next five years the Avian Influenza Vaccines market will register a 5.7% CAGR in terms of revenue, the global market size will reach US$ 1115.9 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Avian Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- H5+H7 Avian Influenza Vaccines

- H9 Avian Influenza Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Chicken Avian Influenza Vaccines

- Duck & Goose Avian Influenza Vaccines

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- Merial

- QYH Biotech

- DHN

- HVRI

- CEVA

- Elanco (Lohmann )

- Yebio

- Zoetis

- FATRO

- Kyoto Biken

- CAVAC

- Ringpu Biology

- Vaksindo

- ChengDu Tecbond

- Sindh Poultry Vaccine Centre

- Merck Animal Health

- Medion

- Avimex Animal Health

- JOVAC

- Bio-Labs

Global Avian Influenza Vaccines Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Avian Influenza Vaccines Consumption 2016-2026
2.1.2 Avian Influenza Vaccines Consumption CAGR by Region
2.2 Avian Influenza Vaccines Segment by Type
2.2.1 H5+H7 Avian Influenza Vaccines
2.2.2 H9 Avian Influenza Vaccines
2.3 Avian Influenza Vaccines Sales by Type
2.3.1 Global Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
2.3.2 Global Avian Influenza Vaccines Revenue and Market Share by Type (2016-2021)
2.3.3 Global Avian Influenza Vaccines Sale Price by Type (2016-2021)
2.4 Avian Influenza Vaccines Segment by Application
2.4.1 Chicken Avian Influenza Vaccines
2.4.2 Duck & Goose Avian Influenza Vaccines
2.4.3 Other
2.5 Avian Influenza Vaccines Sales by Application
2.5.1 Global Avian Influenza Vaccines Sale Market Share by Application (2016-2021)
2.5.2 Global Avian Influenza Vaccines Revenue and Market Share by Application (2016-2021)
2.5.3 Global Avian Influenza Vaccines Sale Price by Application (2016-2021)

3 Global Avian Influenza Vaccines by Company
3.1 Global Avian Influenza Vaccines Sales Market Share by Company
3.1.1 Global Avian Influenza Vaccines Sales by Company (2019-2021)
3.1.2 Global Avian Influenza Vaccines Sales Market Share by Company (2019-2021)
3.2 Global Avian Influenza Vaccines Revenue Market Share by Company
3.2.1 Global Avian Influenza Vaccines Revenue by Company (2019-2021)
3.2.2 Global Avian Influenza Vaccines Revenue Market Share by Company (2019-2021)
3.3 Global Avian Influenza Vaccines Sale Price by Company
3.4 Global Manufacturers Avian Influenza Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Avian Influenza Vaccines Product Location Distribution
3.4.2 Players Avian Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Avian Influenza Vaccines by Region
4.1 Global Avian Influenza Vaccines by Region
4.1.1 Global Avian Influenza Vaccines Sales by Region
4.1.2 Global Avian Influenza Vaccines Revenue by Region
4.2 Americas Avian Influenza Vaccines Sales Growth
4.3 APAC Avian Influenza Vaccines Sales Growth
4.4 Europe Avian Influenza Vaccines Sales Growth
4.5 Middle East & Africa Avian Influenza Vaccines Sales Growth

5 Americas
5.1 Americas Avian Influenza Vaccines Sales by Country
5.1.1 Americas Avian Influenza Vaccines Sales by Country (2016-2021)
5.1.2 Americas Avian Influenza Vaccines Revenue by Country (2016-2021)
5.2 Americas Avian Influenza Vaccines Sales by Type
5.3 Americas Avian Influenza Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Avian Influenza Vaccines Sales by Region
6.1.1 APAC Avian Influenza Vaccines Sales by Region (2016-2021)
6.1.2 APAC Avian Influenza Vaccines Revenue by Region (2016-2021)
6.2 APAC Avian Influenza Vaccines Sales by Type
6.3 APAC Avian Influenza Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Avian Influenza Vaccines by Country
7.1.1 Europe Avian Influenza Vaccines Sales by Country (2016-2021)
7.1.2 Europe Avian Influenza Vaccines Revenue by Country (2016-2021)
7.2 Europe Avian Influenza Vaccines Sales by Type
7.3 Europe Avian Influenza Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Avian Influenza Vaccines by Country
8.1.1 Middle East & Africa Avian Influenza Vaccines Sales by Country (2016-2021)
8.1.2 Middle East & Africa Avian Influenza Vaccines Revenue by Country (2016-2021)
8.2 Middle East & Africa Avian Influenza Vaccines Sales by Type
8.3 Middle East & Africa Avian Influenza Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Avian Influenza Vaccines Distributors
10.3 Avian Influenza Vaccines Customer

11 Global Avian Influenza Vaccines Market Forecast
11.1 Global Avian Influenza Vaccines Forecast by Region
11.1.1 Global Avian Influenza Vaccines Forecast by Regions (2021-2026)
11.2.2 Global Avian Influenza Vaccines Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Avian Influenza Vaccines Forecast by Type
11.7 Global Avian Influenza Vaccines Forecast by Application

12 Key Players Analysis
12.1 Merial
12.1.1 Merial Company Information
12.1.2 Merial Avian Influenza Vaccines Product Offered
12.1.3 Merial Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merial Main Business Overview
12.1.5 Merial Latest Developments
12.2 QYH Biotech
12.2.1 QYH Biotech Company Information
12.2.2 QYH Biotech Avian Influenza Vaccines Product Offered
12.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 QYH Biotech Main Business Overview
12.2.5 QYH Biotech Latest Developments
12.3 DHN
12.3.1 DHN Company Information
12.3.2 DHN Avian Influenza Vaccines Product Offered
12.3.3 DHN Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 DHN Main Business Overview
12.3.5 DHN Latest Developments
12.4 HVRI
12.4.1 HVRI Company Information
12.4.2 HVRI Avian Influenza Vaccines Product Offered
12.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 HVRI Main Business Overview
12.4.5 HVRI Latest Developments
12.5 CEVA
12.5.1 CEVA Company Information
12.5.2 CEVA Avian Influenza Vaccines Product Offered
12.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 CEVA Main Business Overview
12.5.5 CEVA Latest Developments
12.6 Elanco (Lohmann )
12.6.1 Elanco (Lohmann ) Company Information
12.6.2 Elanco (Lohmann ) Avian Influenza Vaccines Product Offered
12.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Elanco (Lohmann ) Main Business Overview
12.6.5 Elanco (Lohmann ) Latest Developments
12.7 Yebio
12.7.1 Yebio Company Information
12.7.2 Yebio Avian Influenza Vaccines Product Offered
12.7.3 Yebio Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Yebio Main Business Overview
12.7.5 Yebio Latest Developments
12.8 Zoetis
12.8.1 Zoetis Company Information
12.8.2 Zoetis Avian Influenza Vaccines Product Offered
12.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Zoetis Main Business Overview
12.8.5 Zoetis Latest Developments
12.9 FATRO
12.9.1 FATRO Company Information
12.9.2 FATRO Avian Influenza Vaccines Product Offered
12.9.3 FATRO Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 FATRO Main Business Overview
12.9.5 FATRO Latest Developments
12.10 Kyoto Biken
12.10.1 Kyoto Biken Company Information
12.10.2 Kyoto Biken Avian Influenza Vaccines Product Offered
12.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Kyoto Biken Main Business Overview
12.10.5 Kyoto Biken Latest Developments
12.11 CAVAC
12.11.1 CAVAC Company Information
12.11.2 CAVAC Avian Influenza Vaccines Product Offered
12.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 CAVAC Main Business Overview
12.11.5 CAVAC Latest Developments
12.12 Ringpu Biology
12.12.1 Ringpu Biology Company Information
12.12.2 Ringpu Biology Avian Influenza Vaccines Product Offered
12.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Ringpu Biology Main Business Overview
12.12.5 Ringpu Biology Latest Developments
12.13 Vaksindo
12.13.1 Vaksindo Company Information
12.13.2 Vaksindo Avian Influenza Vaccines Product Offered
12.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Vaksindo Main Business Overview
12.13.5 Vaksindo Latest Developments
12.14 ChengDu Tecbond
12.14.1 ChengDu Tecbond Company Information
12.14.2 ChengDu Tecbond Avian Influenza Vaccines Product Offered
12.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 ChengDu Tecbond Main Business Overview
12.14.5 ChengDu Tecbond Latest Developments
12.15 Sindh Poultry Vaccine Centre
12.15.1 Sindh Poultry Vaccine Centre Company Information
12.15.2 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Offered
12.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Sindh Poultry Vaccine Centre Main Business Overview
12.15.5 Sindh Poultry Vaccine Centre Latest Developments
12.16 Merck Animal Health
12.16.1 Merck Animal Health Company Information
12.16.2 Merck Animal Health Avian Influenza Vaccines Product Offered
12.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Merck Animal Health Main Business Overview
12.16.5 Merck Animal Health Latest Developments
12.17 Medion
12.17.1 Medion Company Information
12.17.2 Medion Avian Influenza Vaccines Product Offered
12.17.3 Medion Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Medion Main Business Overview
12.17.5 Medion Latest Developments
12.18 Avimex Animal Health
12.18.1 Avimex Animal Health Company Information
12.18.2 Avimex Animal Health Avian Influenza Vaccines Product Offered
12.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Avimex Animal Health Main Business Overview
12.18.5 Avimex Animal Health Latest Developments
12.19 JOVAC
12.19.1 JOVAC Company Information
12.19.2 JOVAC Avian Influenza Vaccines Product Offered
12.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 JOVAC Main Business Overview
12.19.5 JOVAC Latest Developments
12.20 Bio-Labs
12.20.1 Bio-Labs Company Information
12.20.2 Bio-Labs Avian Influenza Vaccines Product Offered
12.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Bio-Labs Main Business Overview
12.20.5 Bio-Labs Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Avian Influenza Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of H5+H7 Avian Influenza Vaccines
Table 3. Major Players of H9 Avian Influenza Vaccines
Table 4. Global Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 5. Global Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 6. Global Avian Influenza Vaccines Revenue by Type (2016-2021) & ($ million)
Table 7. Global Avian Influenza Vaccines Revenue Market Share by Type (2016-2021)
Table 8. Global Avian Influenza Vaccines Sale Price by Type (2016-2021)
Table 9. Global Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 10. Global Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 11. Global Avian Influenza Vaccines Value by Application (2016-2021)
Table 12. Global Avian Influenza Vaccines Revenue Market Share by Application (2016-2021)
Table 13. Global Avian Influenza Vaccines Sale Price by Application (2016-2021)
Table 14. Global Avian Influenza Vaccines Sales by Company (2019-2021) & (M Doses)
Table 15. Global Avian Influenza Vaccines Sales Market Share by Company (2019-2021)
Table 16. Global Avian Influenza Vaccines Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Avian Influenza Vaccines Revenue Market Share by Company (2019-2021)
Table 18. Global Avian Influenza Vaccines Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Avian Influenza Vaccines Producing Area Distribution and Sales Area
Table 20. Players Avian Influenza Vaccines Products Offered
Table 21. Avian Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Avian Influenza Vaccines Sales by Region (2016-2021) (M Doses)
Table 25. Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 26. Global Avian Influenza Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
Table 28. Americas Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 29. Americas Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 30. Americas Avian Influenza Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 32. Americas Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 33. Americas Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 34. Americas Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 35. Americas Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 36. APAC Avian Influenza Vaccines Sales by Region (2016-2021) & (M Doses)
Table 37. APAC Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 38. APAC Avian Influenza Vaccines Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
Table 40. APAC Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 41. APAC Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 42. APAC Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 43. APAC Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 44. Europe Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 45. Europe Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 46. Europe Avian Influenza Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 48. Europe Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 49. Europe Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 50. Europe Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 51. Europe Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 53. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Avian Influenza Vaccines Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Avian Influenza Vaccines Sales by Type (2016-2021) & (M Doses)
Table 57. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Avian Influenza Vaccines Sales by Application (2016-2021) & (M Doses)
Table 59. Middle East & Africa Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Avian Influenza Vaccines
Table 61. Key Application and Potential Industries of Avian Influenza Vaccines
Table 62. Key Challenges of Avian Influenza Vaccines
Table 63. Key Trends of Avian Influenza Vaccines
Table 64. Avian Influenza Vaccines Distributors List
Table 65. Avian Influenza Vaccines Customer List
Table 66. Global Avian Influenza Vaccines Sales Forecast by Region (2021-2026) & (M Doses)
Table 67. Global Avian Influenza Vaccines Consumption Market Forecast by Region
Table 68. Global Avian Influenza Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Avian Influenza Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Avian Influenza Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 71. Americas Avian Influenza Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Avian Influenza Vaccines Sales Forecast by Region (2021-2026) & (M Doses)
Table 73. APAC Avian Influenza Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Avian Influenza Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 75. Europe Avian Influenza Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Avian Influenza Vaccines Sales Forecast by Country (2021-2026) & (M Doses)
Table 77. Middle East & Africa Avian Influenza Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Avian Influenza Vaccines Sales Forecast by Type (2021-2026) & (M Doses)
Table 79. Global Avian Influenza Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Avian Influenza Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Avian Influenza Vaccines Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Avian Influenza Vaccines Sales Forecast by Application (2021-2026) & (M Doses)
Table 83. Global Avian Influenza Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Avian Influenza Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Avian Influenza Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 86. Merial Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 87. Merial Avian Influenza Vaccines Product Offered
Table 88. Merial Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 89. Merial Main Business
Table 90. Merial Latest Developments
Table 91. QYH Biotech Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. QYH Biotech Avian Influenza Vaccines Product Offered
Table 93. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 94. QYH Biotech Main Business
Table 95. QYH Biotech Latest Developments
Table 96. DHN Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. DHN Avian Influenza Vaccines Product Offered
Table 98. DHN Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 99. DHN Main Business
Table 100. DHN Latest Developments
Table 101. HVRI Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. HVRI Avian Influenza Vaccines Product Offered
Table 103. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 104. HVRI Main Business
Table 105. HVRI Latest Developments
Table 106. CEVA Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. CEVA Avian Influenza Vaccines Product Offered
Table 108. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 109. CEVA Main Business
Table 110. CEVA Latest Developments
Table 111. Elanco (Lohmann ) Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Elanco (Lohmann ) Avian Influenza Vaccines Product Offered
Table 113. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 114. Elanco (Lohmann ) Main Business
Table 115. Elanco (Lohmann ) Latest Developments
Table 116. Yebio Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. Yebio Avian Influenza Vaccines Product Offered
Table 118. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 119. Yebio Main Business
Table 120. Yebio Latest Developments
Table 121. Zoetis Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 122. Zoetis Avian Influenza Vaccines Product Offered
Table 123. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 124. Zoetis Main Business
Table 125. Zoetis Latest Developments
Table 126. FATRO Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 127. FATRO Avian Influenza Vaccines Product Offered
Table 128. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 129. FATRO Main Business
Table 130. FATRO Latest Developments
Table 131. Kyoto Biken Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 132. Kyoto Biken Avian Influenza Vaccines Product Offered
Table 133. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 134. Kyoto Biken Main Business
Table 135. Kyoto Biken Latest Developments
Table 136. CAVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 137. CAVAC Avian Influenza Vaccines Product Offered
Table 138. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 139. CAVAC Main Business
Table 140. CAVAC Latest Developments
Table 141. Ringpu Biology Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 142. Ringpu Biology Avian Influenza Vaccines Product Offered
Table 143. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 144. Ringpu Biology Main Business
Table 145. Ringpu Biology Latest Developments
Table 146. Vaksindo Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 147. Vaksindo Avian Influenza Vaccines Product Offered
Table 148. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 149. Vaksindo Main Business
Table 150. Vaksindo Latest Developments
Table 151. ChengDu Tecbond Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 152. ChengDu Tecbond Avian Influenza Vaccines Product Offered
Table 153. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 154. ChengDu Tecbond Main Business
Table 155. ChengDu Tecbond Latest Developments
Table 156. Sindh Poultry Vaccine Centre Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 157. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Offered
Table 158. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 159. Sindh Poultry Vaccine Centre Main Business
Table 160. Sindh Poultry Vaccine Centre Latest Developments
Table 161. Merck Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 162. Merck Animal Health Avian Influenza Vaccines Product Offered
Table 163. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 164. Merck Animal Health Main Business
Table 165. Merck Animal Health Latest Developments
Table 166. Medion Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 167. Medion Avian Influenza Vaccines Product Offered
Table 168. Medion Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 169. Medion Main Business
Table 170. Medion Latest Developments
Table 171. Avimex Animal Health Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 172. Avimex Animal Health Avian Influenza Vaccines Product Offered
Table 173. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 174. Avimex Animal Health Main Business
Table 175. Avimex Animal Health Latest Developments
Table 176. JOVAC Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 177. JOVAC Avian Influenza Vaccines Product Offered
Table 178. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 179. JOVAC Main Business
Table 180. JOVAC Latest Developments
Table 181. Bio-Labs Basic Information, Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 182. Bio-Labs Avian Influenza Vaccines Product Offered
Table 183. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E)
Table 184. Bio-Labs Main Business
Table 185. Bio-Labs Latest Developments
List of Figures
Figure 1. Picture of Avian Influenza Vaccines
Figure 2. Avian Influenza Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Avian Influenza Vaccines Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global Avian Influenza Vaccines Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Avian Influenza Vaccines Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of H5+H7 Avian Influenza Vaccines
Figure 10. Product Picture of H9 Avian Influenza Vaccines
Figure 11. Global Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 12. Global Avian Influenza Vaccines Revenue Market Share by Type (2016-2021)
Figure 13. Avian Influenza Vaccines Consumed in Chicken Avian Influenza Vaccines
Figure 14. Global Avian Influenza Vaccines Market: Chicken Avian Influenza Vaccines (2016-2021) & (M Doses)
Figure 15. Avian Influenza Vaccines Consumed in Duck & Goose Avian Influenza Vaccines
Figure 16. Global Avian Influenza Vaccines Market: Duck & Goose Avian Influenza Vaccines (2016-2021) & (M Doses)
Figure 17. Avian Influenza Vaccines Consumed in Other
Figure 18. Global Avian Influenza Vaccines Market: Other (2016-2021) & (M Doses)
Figure 19. Global Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Figure 20. Global Avian Influenza Vaccines Revenue Market Share by Application in 2020
Figure 21. Avian Influenza Vaccines Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Avian Influenza Vaccines Revenue Market Share by Company in 2020
Figure 23. Global Avian Influenza Vaccines Sales Market Share by Regions (2016-2021)
Figure 24. Global Avian Influenza Vaccines Revenue Market Share by Region in 2020
Figure 25. Americas Avian Influenza Vaccines Sales 2016-2021 (M Doses)
Figure 26. Americas Avian Influenza Vaccines Revenue 2016-2021 ($ Millions)
Figure 27. APAC Avian Influenza Vaccines Sales 2016-2021 (M Doses)
Figure 28. APAC Avian Influenza Vaccines Revenue 2016-2021 ($ Millions)
Figure 29. Europe Avian Influenza Vaccines Sales 2016-2021 (M Doses)
Figure 30. Europe Avian Influenza Vaccines Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Avian Influenza Vaccines Sales 2016-2021 (M Doses)
Figure 32. Middle East & Africa Avian Influenza Vaccines Revenue 2016-2021 ($ Millions)
Figure 33. Americas Avian Influenza Vaccines Sales Market Share by Country in 2020
Figure 34. Americas Avian Influenza Vaccines Revenue Market Share by Country in 2020
Figure 35. Americas Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 36. Americas Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 37. United States Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Avian Influenza Vaccines Sales Market Share by Region in 2020
Figure 42. APAC Avian Influenza Vaccines Revenue Market Share by Regions in 2020
Figure 43. APAC Avian Influenza Vaccines Sales Market Share by Type in 2020
Figure 44. APAC Avian Influenza Vaccines Sales Market Share by Application in 2020
Figure 45. China Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Avian Influenza Vaccines Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Avian Influenza Vaccines Sales Market Share by Cou
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs